slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 205,321-205,350
Pages 10,126
Rows per page 30
Component
205,321-205,350 of 303,780
09
The chart uses a combination of grouped bar charts for absolute values and line charts for percentage metrics.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations 1 hit
10
Includes numbered callouts linking table rows to specific highlights.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · Financials1 hit
11
The chart tracks loan composition across five categories: Commercial & Industrial, CRE Owner Occupied, CRE Non-Owner Occupied, Construction & Land, and Residential & Consumer.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · Financials1 hit
13
Includes three charts: a stacked bar chart for classified assets, a combo chart for special mention loans, and a line chart for asset quality ratios.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · Financials1 hit
14
Includes footnotes regarding credit linked notes and loan portfolio coverage.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · Financials1 hit
15
Uses a before-after framework to show portfolio evolution from a concentrated local model to a diversified national model.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
16
Peer medians compare 33 publicly traded banks headquartered in the U.S. with total assets between $25B and $150B.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a comparative table to establish market leadership in risk-adjusted returns.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations Beat · Solution1 hit
18
Slide 18 of a financial presentation.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations 1 hit
19
The chart compares WAL performance against a peer group of 33 banks with assets between $25B and $150B.Western Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations 1 hit
20
Western Alliance Bancorporation | Results Presentation Deck | 21 slidesWestern Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations 1 hit
21
Western Alliance Bancorporation | Results Presentation Deck | 21 slidesWestern Alliance Bancorporation | Results Presentation Deck | 21 slides · Western Alliance Bancorporation
Conference presentation Investor relations 1 hit
02
Wintrust Financial | Results Presentation Deck | 23 slidesWintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations Beat · Attention1 hit
03
Wintrust Financial | Results Presentation Deck | 23 slidesWintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations Beat · Attention1 hit
04
Wintrust Financial | Results Presentation Deck | 23 slidesWintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations Beat · Attention1 hit
07
Includes a waterfall chart showing growth components and a donut chart for portfolio mix.Wintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations Beat · Interest1 hit
12
Includes four distinct charts and a summary table for MSR metrics.Wintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
14
Includes a specific callout regarding Hurricane Ian exposure in Florida.Wintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
20
Wintrust Financial | Results Presentation Deck | 23 slidesWintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations 1 hit
21
Wintrust Financial | Results Presentation Deck | 23 slidesWintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations 1 hit
22
Includes two distinct reconciliation tables for different financial metrics.Wintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations 1 hit
23
Includes both quarterly and annual historical data for Wintrust Financial.Wintrust Financial | Results Presentation Deck | 23 slides · Wintrust Financial
Conference presentation Investor relations 1 hit
01
Includes Exhibit 99.2 reference and copyright notice.Xeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations 1 hit
02
Xeris Biopharma | Investor Presentation Deck | 11 slidesXeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations 1 hit
03
Xeris Biopharma | Investor Presentation Deck | 11 slidesXeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations 1 hit
05
Xeris Biopharma | Investor Presentation Deck | 11 slidesXeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
06
The slide outlines a clinical trial structure involving two parts, with crossover periods for Part 1.Xeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
07
The chart compares subcutaneous (SC) administration of XP-8121 against oral (PO) administration of Synthroid.Xeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Clinical trial data (XP-8121-108) comparing subcutaneous (SC) vs oral (PO) administration.Xeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Xeris Biopharma | Investor Presentation Deck | 11 slidesXeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations Beat · Key TakeawaysLoop · Golden Circle1 hit